Mentioned 2 times on 1 show.
“compared to these obscure peptides like BPC-157, TB-500, TB-4, that don't have a clear target. They have receptors, but they just have many of them, or they don't even have receptors? We don't have a receptor identity. We haven't identified for BPC-157 or TB-4. Just stopping right there. There's a very interesting distinction.”
“So you'll get more blood vessels, andiogenesis being formed, which creates a lot of the controversy around BPC safety. You'll get cell migration, especially when coupled with TB500 and TB4. You'll get more access of the healing factors to the area through androgenic pathways. On top of that, you'll get an anti-stress effect.”